Shandong Xinhua Pharmaceutical Company Limited Class H Financial Overview
Shandong Xinhua Pharmaceutical Company Limited Class H's market cap is currently HK$9.99B. The company's EPS TTM is HK$0.051; its P/E ratio is 11.28; and it has a dividend yield of 4.44%. Shandong Xinhua Pharmaceutical Company Limited Class H is scheduled to report earnings on October 24, 2025, and the estimated EPS forecast is HK$0.23. See an overview of income statement, balance sheet, and cash flow financials.
